Friday, May 11, 2012 4:37 PM
|
CCSVI in Multiple Sclerosis
CCSVI Alliance president Sharon Richardson interviewed by ABC News of the FDA alert-- FDA Alert on Controversial MS Therapyabcnews.go.com The FDA warns that an experimental therapy is unproven and could be risky.
|